Novavax files for emergency use listing of Covid-19 vaccine with WHO
Biotechnology firm Novavax Inc said it has completed the rolling submission for the emergency use listing (EUL) of its Covid-19 vaccine candidate to the World Health Organization (WHO). Novavax will make further submissions to enable vaccine supply from additional manufacturing sites in Novavax' global supply chain.
Post a Comment